. Author manuscript; available in PMC: 2022 Aug 1.

Published in final edited form as: Mol Genet Metab. 2021 Jun 2;133(4):352–361. doi: 10.1016/j.ymgme.2021.05.010

Table 2.

Enriched KEGG pathways of differentially expressed proteins

Pathway Description	Genes	P value	FDR q-value
Parkinson’s disease	Uqcrc2\|Sept5\|Sdha\|Th\|Atp5c1	0.003	0.259453884
Valine, leucine, and isoleucine degradation	Mccc2\|Hsd17b10\|Mccc1	0.022	0.643639237
Metabolic pathways	Uqcrc2\|Sdha\|Th\|Atp5c1\|Mccc2\|Hsd17b10\|Mccc1\|Dgkb\|SRM\|Ckmt1\|Sucla2	0.029	0.598691922
Alzheimer’s disease	UQCRC2\|SDHA\|ATP5C1\|HSD17B10	0.036	0.582326059
GABAergic synapse	Gabrb2\|Gnb5\|Prkcg	0.050	0.621737675
Morphine addiction	Gabrb2\|Gnb5\|Prkcg	0.057	0.599647403
Retrograde endocannabinoid signaling	Gabrb2\|Gnb5\|Prkcg	0.068	0.611250528
Carbon metabolism	Me2\|Sdha\|Sucla2	0.083	0.640892686